Abhinav Mishra
You can view my complete CV as PDF here.
Education
Master of Science, Bioinformatics
Freie Universität Berlin, Germany — 2025
Thesis: Mathematical Optimization of Signalling Networks in Triple Negative Breast Cancer Cell LinesBachelor of Technology, Bioinformatics
Jaypee University of Information Technology, India — 2017
Thesis: Identification of Potent Biomarkers for Prostate Cancer Through AR, MAPK, and mTOR Signalling Pathway Mining
Experience
Research Intern — Institute for Biology, HU Berlin (Jan 2025 – Feb 2025)
Developed a physiologically based pharmacokinetic model for Tirzepatide using curated clinical data and parameter optimization.
GitHubMaster Thesis Student — Theoretical Biophysics, HU Berlin (May 2024 – Jan 2025)
Built and validated an optimization framework to reconstruct triple-negative breast cancer phosphorylation networks from LC-MS and kinase-substrate data using Differential Evolution and Sequential Least Squares Programming.
GitHubBachelor Thesis Student — JUIT, India (Feb 2016 – Mar 2017)
Designed a pipeline using GEO2R, MeV, WB-DEGS, and R/Shiny to identify and validate prostate cancer biomarkers.
GitHubProject Researcher — JUIT, India (Aug 2015 – Mar 2016)
Developed a docking workflow with Discovery Studio, Maestro, and Glide XP to screen FDA-approved drugs against the Dopamine D3 receptor. Analyzed interactions using PyMol & VMD.
GitHub
Software & Tools
See Projects for details.
Publications
- Mishra, A. & König, M. Physiologically Based Pharmacokinetic (PBPK) Model of Tirzepatide. Zenodo, 2025. DOI
- Asati, N., Mishra, A., Shukla, A., Singh, T. Gene Expression Studies to Identify Significant Genes in AR, MTOR, MAPK Pathways and their Overlapping Regulatory Role in Prostate Cancer. J. Integrative Bioinformatics, 16(3), 2019. DOI
Awards & Honours
- 3rd Prize, Poster Presentation, NSCSB 2016, JUIT India
- GATE Qualified, All India Rank 681 (2018)
Community & Membership
Administrator, BioBaes (since 2020)
Non-profit community for bioinformatics enthusiasts. Focused on mentoring, open knowledge, and creating accessible opportunities.Member, International Society for Computational Biology (ISCB) — 1 year